<DOC>
	<DOCNO>NCT00035061</DOCNO>
	<brief_summary>Patients bladder cancer participate study treatment abnormal cell bladder return initial treatment OR move new site body .</brief_summary>
	<brief_title>A Phase 2 Trial ALIMTA ( Pemetrexed ) Locally Advanced Metastatic Recurrent Transitional Cell Carcinoma Urothelium</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Urologic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>You must diagnose bladder cancer recur move new part body . You must least one tumor physically measure scanned xray . You may previous chemotherapy ( drug ) treatment OR surgery follow one chemotherapy treatment least 4 month ago . You may use experimental medicine device within past month . Cancer spread brain . If unwilling unable take folic acid vitamin B12 supplement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Bladder Cancer</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Recurrent</keyword>
	<keyword>Transitional cell carcinoma urothelium</keyword>
</DOC>